May 19 (Reuters) - Anika Therapeutics Inc ANIK.O
* Announces Canadian launch of cingal for the treatment of
pain associated with osteoarthritis of the knee
* Cingal will be marketed and sold in Canada by Pendopharm,
a division of Pharmascience Inc, a Quebec-based pharmaceutical
company
Source text for Eikon: ID:nBw7L6TcWa
Further company coverage: ANIK.O
(Bengaluru Newsroom: +1-646-223-8780)